Metabolite information |
|
| HMDB ID | HMDB0007970 |
| Synonyms |
1-Palmitoyl-2-stearoyl-sn-glycero-3-phosphorylcholine1-Palmitoyl-2-stearoylphosphatidylcholine1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine1-palmitoyl-2-stearoyl-sn-glycero-3-phosphocholineCellular membraneDietary supplementDigestionExtracellular regionFaunaInner membraneLecithinLipid metabolic processMembrane integrity agentMembrane stability agentNutraceuticalPC[16:0/18:0]PC[34:0]Phosphatidylcholine[16:0/18:0]Phosphatidylcholine[34:0]Signal transductionSurface-active agent[2R]-3-[Palmitoyloxy]-2-[stearoyloxy]propyl 2-[trimethylammonio]ethyl phosphate[2R]-3-[Palmitoyloxy]-2-[stearoyloxy]propyl 2-[trimethylammonio]ethyl phosphoric acidgpcho[16:0/18:0]gpcho[34:0] |
| Chemical formula | C42H84NO8P |
| IUPAC name | (2-{[(2R)-3-(hexadecanoyloxy)-2-(octadecanoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium |
| CAS registry number | – |
| Monisotopic molecular weight | 761.593455181 |
Chemical taxonomy |
|
| Super class | Lipids and lipid-like molecules |
| Class | Glycerophospholipids |
| Sub class | Glycerophosphocholines |
Biological properties |
|
| Pahtways |
|
| Author-emphasized biomarker in the paper(s) |
|
| Reference | Country | Specimen | Marker function | Participants (Case) | Participants (Control) | |||||||||
| Cancer type | Stage | Number | Gender (M,F) | Age mean (range) (M/F) | Smoking status | Type | Number | Gender (M,F) | Age mean (range) (M/F) | Smoking status | ||||
| Chen et al. 2018 | – | serum | diagnosis | NSCLC | I, II | 90 | 40, 50 | 58.1 ± 9.0 | – | healthy | 90 | 42, 48 | 53.0 ± 11.8 | – |
| Callejón-Leblic et al. 2019 | – | blood | diagnosis | NSCLC, SCLC | II, III, IV | 30 | 25, 5 | 67 ± 12 | former, current, non-smoker | healthy | 30 | 14, 16 | 56 ± 14 | former, non-smoker |
| Reference | Chromatography | Ion source | Positive/Negative mode | Mass analyzer | Identification level |
| Chen et al. 2018 | LC | ESI | positive/ negative | Q-TOF | – |
| Callejón-Leblic et al. 2019 | DI | ESI | positive | Q-TOF | MS/MS |
| Reference | Data processing software | Database search |
| Chen et al. 2018 | Analyst TF, XCMS | – |
| Callejón-Leblic et al. 2019 | – | HMDB, Metlin |
| Reference | Difference method | Mean concentration (case) | Mean concentration (control) | Fold change (case/control) | P-value | FDR | VIP |
| Chen et al. 2018 | Student’s t-test | 140.06 ng/mL | 117.01 ng/mL | – | 0.066 | 0.0729 | – |
| Callejón-Leblic et al. 2019 | PCA, PLS-DA, one-way ANOVA | – | – | 1.67 | 0.014 | – | 1.17 |
| Reference | Classification method | Cutoff value | AUROC 95%CI | Sensitivity (%) | Specificity (%) | Accuracy (%) |
| Chen et al. 2018 | ROC curve | – | – | – | – | – |
| Callejón-Leblic et al. 2019 | ROC curve | – | 0.67 | – | – | – |